Evaluation of Clinical Outcomes According to HER2 Detection by Fluorescence In Situ Hybridization in Women with Metastatic Breast Cancer Treated with Trastuzumab

These data indicate that assessment of HER2 amplification by FISH is the preferred method to select patients for trastuzumab therapy.